Chromone: a valid scaffold in medicinal chemistry

A Gaspar, MJ Matos, J Garrido, E Uriarte… - Chemical …, 2014 - ACS Publications
Chromones are a group of naturally occurring compounds that are ubiquitous in nature,
especially in plants. The word chromone is derived from the Greek word chroma, meaning …

Privileged scaffolds as MAO inhibitors: Retrospect and prospects

AC Tripathi, S Upadhyay, S Paliwal, SK Saraf - European Journal of …, 2018 - Elsevier
This review aims to be a comprehensive, authoritative, critical, and readable review of
general interest to the medicinal chemistry community because it focuses on the …

New frontiers in selective human MAO-B inhibitors: miniperspective

S Carradori, R Silvestri - Journal of medicinal chemistry, 2015 - ACS Publications
Accumulating evidence shows a relationship between the human MAO-B (hMAO-B) enzyme
and neuropsychiatric/degenerative disorder, personality traits, type II alcoholism, borderline …

Monoamine oxidase B inhibitors based on natural privileged scaffolds: A review of systematically structural modification

Y Lv, Z Zheng, R Liu, J Guo, C Zhang, Y Xie - International Journal of …, 2023 - Elsevier
Monoamine oxidase is a flavin enzyme that catalyzes the oxidation of monoamine
neurotransmitters in the brain. Various toxic by-products, aldehydes and hydrogen peroxide …

Recent developments on the structure–activity relationship studies of MAO inhibitors and their role in different neurological disorders

B Kumar, AK Mantha, V Kumar - RSC advances, 2016 - pubs.rsc.org
Monoamine oxidase (MAO) enzyme catalyzes the oxidative deamination of xenobiotic and
endogenous amines including many neurotransmitters. The MAO enzyme exists in two …

Chromone, a privileged scaffold in drug discovery: Developments in the synthesis and bioactivity

AT Benny, SD Arikkatt, CG Vazhappilly… - Mini Reviews in …, 2022 - ingentaconnect.com
Chromones are the class of secondary metabolites that broadly occur in the plant kingdom
in a noticeable quantity. This rigid bicyclic system has been categorized “as privileged …

Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors

A Gaspar, T Silva, M Yánez, D Vina… - Journal of medicinal …, 2011 - ACS Publications
Two series of novel chromone derivatives were synthesized and investigated for their ability
to inhibit the activity of monoamine oxidase. The SAR data indicate that chromone …

Discovery of new chemical entities for old targets: insights on the lead optimization of chromone-based monoamine oxidase B (MAO-B) inhibitors

J Reis, F Cagide, D Chavarria, T Silva… - Journal of medicinal …, 2016 - ACS Publications
The discovery of new chemical entities endowed with potent, selective, and reversible
monoamine oxidase B inhibitory activity is a clinically relevant subject. Therefore, a small …

Synthesis, structure–activity relationship of novel substituted 4H-chromen-1, 2, 3, 4-tetrahydropyrimidine-5-carboxylates as potential anti-mycobacterial and anticancer …

BC Raju, RN Rao, P Suman, P Yogeeswari… - Bioorganic & Medicinal …, 2011 - Elsevier
Abstract Series of 4H-chromen-1, 2, 3, 4-tetrahydropyrimidine-5-carboxylate derivatives 7a–
7zb, 8a–8d and 9a–9d were synthesized and screened for their in vitro anti-mycobacterial …

Multi-target-directed ligands for Alzheimer's disease: Discovery of chromone-based monoamine oxidase/cholinesterase inhibitors

J Reis, F Cagide, ME Valencia, J Teixeira… - European Journal of …, 2018 - Elsevier
There has been a substantial research effort to design multi-target ligands for the treatment
of Alzheimer's disease (AD), an approach that is moved by the knowledge that AD is a …